Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 237

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 237
---
 to be entered into in connection
therewith and other open items.

Between September
6 and September 9, 2024, Longevity and FutureTech discussed a proposal from FutureTech to increase the valuation of Longevity from $75.0
million to $100.0 million. On September 10, 2024, the parties agreed to the updated valuation.

On September 16,
2024, Newbridge delivered its fairness opinion to FutureTech, the FutureTech Board and the Longevity Board approved the proposed business
combination and the entry into the Merger Agreement, and the parties executed the Merger Agreement.

On September 20,
2024, Longevity and FutureTech issued a joint press release announcing the execution of the Merger Agreement, which it filed with a Current
Report on Form 8-K with the SEC along with the executed Merger Agreement, the executed Sponsor Support Agreement and Longevity Support
Agreement, and an investor presentation prepared by members of Longevity’s and FutureTech’s management team regarding Longevity
and the Business Combination. The joint press release disclosed the proposed transaction.

On September 30,
2024, representatives of Longevity and Maxim met to discuss potential PIPE transaction alternatives.

On October 8,
2024, representatives of Longevity and Nelson Mullins met to discuss a potential PIPE transaction with the PIPE Investor that had been
brought to Longevity by FutureTech. They also discussed a draft securities subscription agreement drafted in connection with such proposed
transaction to be entered into by FutureTech and the PIPE Investor.

On November 7,
2024, Mr. Ray Chen, Mr. Bradford A. Zakes, and representatives of Yorkville Advisors, LP met to discuss potential PIPE transaction alternatives.

In November 2024
and early December 2024, Nelson Mullins and Moses Singer continued to negotiate and draft the securities subscription agreement to be
entered into by FutureTech and the PIPE Investor.

On December 13,
2024, FutureTech entered into a subscription agreement with the PIPE Investor in connection with the PIPE Investment, pursuant to which
the PIPE Investor agreed to subscribe and purchase 1,000,000 shares of FutureTech Common Stock, at a price of $5 per share.

| 118 |

Projected Financial Information

General

In connection
with its consideration of the Business Combination, FutureTech was provided with the projections prepared by the senior management of
Longevity (the “Projections”) on July 3, 2024. The Projections are included in